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Background: Diverse microbiota exist in the lower respiratory tract. Although next genera-
tion sequencing (NGS) is the most widely used microbiome analysis technique, it is diffi-
cult to implement NGS in clinical microbiology laboratories. Therefore, we evaluated the 
performance of conventional culture methods together with matrix-assisted laser desorp-
tion/ionization time-of-flight mass spectrometry (MALDI-TOF MS) in identifying microbiota 
in bronchoalveolar lavage (BAL) fluid.
Methods: BAL fluid samples (n=27) were obtained from patients undergoing diagnostic 
bronchoscopy for lung mass evaluation. Bacterial and fungal culture was performed with 
conventional media used in clinical microbiology laboratories. On an average, 20 isolated 
colonies were picked from each agar plate and identified by MALDI-TOF MS. Microbiome 
analysis using 16S rRNA NGS was conducted for comparison.
Results: Streptococcus spp. and Neisseria spp. were most frequently cultured from the 
BAL fluid samples. In two samples, Enterobacteriaceae grew predominantly on MacCon-
key agar. Actinomyces and Veillonella spp. were commonly identified anaerobes; gut bac-
teria, such as Lactobacillus, Bifidobacterium, and Clostridium, and fungi were also iso-
lated. NGS revealed more diverse bacterial communities than culture, and Prevotella spp. 
were mainly identified solely by NGS. Some bacteria, such as Staphylococcus spp., Clos-
tridium spp., and Bifidobacterium spp., were identified solely by culture, indicating that 
culture may be more sensitive for detecting certain bacteria.
Conclusions: Culture and NGS of BAL fluid samples revealed common bacteria with some 
different microbial communities. Despite some limitations, culture combined with MALDI-
TOF MS might play a complementary role in microbiome analysis using 16S rRNA NGS.
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INTRODUCTION
Increasing data have demonstrated that colonizing microorgan-
isms might dictate human health and disease [1]. Although the 
2012 Human Microbiome Project did not include the lower re-
spiratory tract in its surveys, advances in sequencing technology 
have revealed a diverse population of non-routinely cultured 
bacteria in the lung, which has traditionally been thought to be 
sterile [2-5]. Most of these studies are based on 16S rRNA next 
generation sequencing (NGS), a highly sensitive method for an-
alyzing the microbiome [6]. Because the human microbiota 
consists of many ‘unculturable’ bacteria, culture-independent 
metagenomic approaches have driven significant advances in 
microbiome research. However, the bacterial species informa-
tion obtainable from these metagenomic approaches might be 
limited, and there are several steps, including nucleic acid ex-
traction, PCR amplification, sequencing (method and depth), 
and bioinformatic analysis, that may produce variations in the 
results. Read length is also one of the most important factors 
when considering clinical application. Hence, the cultivation of 
microbes provides more reliable information regarding the phe-
notype and ecological role, allowing a greater understanding of 
microbe-host interactions [7]. 
Recently, a number of new approaches for gut microbiota cul-
tivation have emerged with potential for use in microbiome re-
search [8]; these have mainly been applied to investigate the 
gut microbiome [9-11]. Although these novel approaches have 
shown that culture can capture a significant subset of the spe-
cies identified using culture-independent methods [8], it is not 
easy to apply these techniques in clinical laboratories. In addi-
tion, limited information is available regarding culture-based mi-
crobiome analysis of the respiratory tract compared with that of 
the gut. We used culture conditions commonly adopted in con-
ventional clinical microbiology laboratories to explore the micro-
biota in bronchoalveolar lavage (BAL) fluid compared with the 
microbiome results obtained via 16S rRNA NGS.  
METHODS
1. Sample collection
BAL fluid samples were collected from patients undergoing 
bronchoscopy procedures for lung mass evaluation at Sever-
ance Hospital, Seoul, Korea from May to November 2015. The 
bronchoscope was inserted through the mouth, and BAL was 
collected according to a standardized protocol at the opposite 
side of the lung mass; 10 mL BAL fluid was acquired from the 
patients with approximately 30 mL sterile 0.9% saline. Sample 
was collected in accordance with the Institutional Review Board 
of Severance Hospital (IRB No. 4-2014-1014); informed con-
sent was obtained from the patients. 
2. Culture conditions
BAL fluid samples were cultured on the day within 6 hours of 
collection. Undiluted BAL fluid (100 μL) was inoculated onto an 
agar plate using a spreader. Different agar plates with aerobic 
and anaerobic conditions were used: blood agar (aerobic, 35°C, 
5% CO2), chocolate agar (aerobic, 35°C, 5% CO2), MacConkey 
agar (aerobic, 35°C, 5% CO2), Brucella agar (anaerobic, 35°C), 
phenylethyl alcohol agar (anaerobic, 35°C), and Sabouraud dex-
trose agar (aerobic, 30°C, ambient air). Bacterial colonies were 
isolated after 48 hours of culture. Sabouraud dextrose agar 
(SDA) plates used for fungal culture were observed for up to 
four weeks of incubation. 
3. Bacterial identification
An average of 20 colonies with different morphologies and sizes 
were selected from each agar plate and applied to a Microflex 
LT matrix-assisted laser desorption/ionization time-of-flight mass 
spectrometry (MALDI-TOF MS) system with Biotyper software 
3.1 (Bruker Daltonics, Bremen, Germany) for simultaneous 
identification and subculture. When an accurate identification 
was not available (score <1.7) using only α-cyano-4-hydroxycin-
namic acid, formic acid was added. Strains that could not be 
reliably identified by MALDI-TOF MS were subjected to further 
analysis; the subcultured colonies were analyzed using 16S 
rRNA sequencing for bacteria and ITS sequencing for fungi per-
formed with primers 27F-1492R and ITS4, respectively (Table 
1). To detect Staphylococcus spp., Klebsiella spp., and Entero-
bacter spp. in samples from which bacterial species were iso-
lated solely on culture plates, we performed PCR amplification 
using organism-specific primers as previously described [12-14] 
(Table 1).
4. High-throughput sequencing
DNA was extracted from BAL fluid within 6 hours of sample col-
lection by using the DNeasy Blood & Tissue kit (Qiagen, Venlo, 
Limburg, Netherlands), according to the manufacturer’s proto-
col. DNA extraction was performed simultaneously with bacte-
rial culture. The DNA samples were stored at –70°C until further 
analysis. The 16S rRNA gene from each DNA sample was am-
plified using barcoded fusion primers targeting the V1 to V3 re-
gions (27F-518R), because this region has been reported to be 
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reliable for accurate taxonomic classification of bacterial sequen-
ces [15] (Table 1). Amplification was carried out under the fol-
lowing conditions: initial denaturation at 95°C for 5 minutes; fol-
lowed by 30 cycles of denaturation at 95°C for 30 seconds, 
primer annealing at 55°C for 30 seconds, and extension at 72°C 
for 30 seconds; and a final elongation step at 72°C for 7 minutes. 
PCR products were confirmed using 2% agarose gel electropho-
resis and visualized with a Gel Doc system (BioRad, Hercules, 
CA, USA). The amplified products were purified using the QIA-
quick PCR purification kit (Qiagen). Equal concentrations of pu-
rified products were pooled together, and short fragments (non-
target products) were remov ed using the AMPure beads kit (Agen-
court Bioscience, Beverly, MA, USA). Quality and product size 
were assessed on a Bioanalyzer 2100 (Agilent, Palo Alto, CA, USA) 
using a DNA 7500 chip. Mixed amplicons were obtained by emul-
sion PCR and then deposited on picotiter plates. Sequencing 
was carried out at Chunlab, Inc. (Seoul, Korea) using the GS 
Junior Sequencing system (Roche, Branford, CT, USA) accord-
ing to the manufacturer’s instructions. Reads obtained from dif-
ferent samples were sorted using the unique barcodes on each 
PCR product. The barcode, linker, and primer sequences were 
removed from the original sequencing reads. Any reads con-
taining two or more ambiguous nucleotides, low-quality score 
(average score <25), or reads shorter than 300 bp were dis-
carded. Potential chimera sequences were detected using the 
UCHIME algorithm [16]. Following removal of the chimera se-
quences, the taxonomic classification of each read was assigned 
against the EzTaxon-e database (http://eztaxon-e.ezbiocloud.
net) [17]. 
The operational taxonomic units (OTUs) identified at the ge-
nus level were listed with the number of reads, reflecting the 
relative frequency of detection. Next, the number of cultured 
colonies was compared with the number of OTUs determined 
by NGS in the same sample to analyze the difference in identifi-
cation by NGS and culture. 
RESULTS
1. Culture and MALDI-TOF MS identification
A total of 2,272 microbial colonies were isolated from 27 BAL 
fluid samples and identified using culture and MALDI-TOF MS. 
The number of genera identified per sample ranged from 4 to 
14, with an average of 8. The total number of genera identified 
was 29; these included 85 species. Streptococcus spp. were 
the predominant isolates with a total number of 1,213 colonies 
(Table 2). Culture on blood and MacConkey agar resulted in the 
highest and the lowest number of microorganisms, respectively. 
Forty (1.76%, 40/2,272) colonies were not identified by MALDI-
TOF MS. These colonies were subcultured and re-identified us-
ing MALDI-TOF MS with the aid of formic acid, yielding mainly 
Streptococcus spp. (47.5%, 19/40). Four colonies (0.18%, 4/2,272) 
could not be identified with repeated MALDI-TOF MS; these were 
identified as Actinomyces odontolyticus, Actinomyces gravenit-
zii, Fusobacterium periodonticum, and Aspergillus fumigatus by 
sequencing using 16S rRNA and ITS gene amplification. 
2. 16S rRNA NGS identification
Sequencing using the GS Junior Sequencing system generated 
10,332 valid reads per sample on average (range 6,761–19,764). 
At the genus level, a total of 288 OTUs were identified with a 
mean of 55.8 (range 27–78) per sample. Considering those with 
a relative abundance greater than 1%, the mean number of OTUs 
identified at the genus level was 10.0 (range 6–17) per sample 
(Fig. 1), which is comparable to the number of bacterial genera 
identified using conventional culture and MALDI-TOF MS. Pre-
votella spp. was the most frequent and abundant OTU identified 
at the genus level; it was identified in all 27 samples (relative 
abundance 6.5–54.5% with a mean of 29.2%). The next most 
prevalent OTUs (mean relative abundance) were Streptococcus 
(11.5%), Neisseria (10.5%), Haemophilus (10.1%), and Veil-
lonella (9.1%).
3.  Comparison of microbial identification using culture and 
MALDI-TOF MS vs NGS 
NGS revealed more OTUs compared with the number of genera 
identified by culture (Fig. 1). The relative abundance of bacte-
Table 1. Primers used for 16s rRNA and ITS PCR and sequencing
Primers Sequences (5´-3´) Target
27F GAGTTTGATCMTGGCTCAG Universal bacteria [32]
518R WTTACCGCGGCTGCTGG
27F AGAGTTTGATCMTGGCTCAG Universal bacteria [32]
1492R TACGGYTACCTTGTTACGACTT
ITS4_F TCCGTAGGTGAACCTGCGG Universal fungus [33]
ITS4_R TCCTCCGCTTATTGATATGC
tuf_F GCCAGTTGAGGACGTATTCT Staphylococcus [13]
tuf_R CCATTTCAGTACCTTCTGGTAA
Hemolysin_F CGACCTGATTGCATTCGCCAC Klebsiella modified from [14]
Hemolysin_R TGGTCAACCCAACGATCCTG
rpoB_F CAGGTCGTCACGGTAACAAG Enterobacter [12]
rpoB_F GTGGTTCAGTTTCAGCATGTAC
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Table 2. Number of bacterial and fungal colonies on the culture media, identified by MALDI-TOF MS 
BAP MAC CHO BRU PE SDA Total
Actinomyces gravenitzii 0 0 4 7 0 0 11
Actinomyces odontolyticus 1 0 14 20 17 0 52
Actinomyces oris 6 0 2 0 1 0 9
Bacillus badius 0 0 0 2 0 0 2
Bifidobacterium dentium 0 0 0 0 1 0 1
Bifidobacterium longum 0 0 0 0 2 0 2
Clostridium difficile 0 0 0 5 10 0 15
Corynebacterium argentoratense 6 0 6 0 0 0 12
Corynebacterium durum 2 0 0 0 0 0 2
Corynebacterium pseudodiphtheriticum 0 0 2 0 0 0 2
Escherichia coli 0 1 0 0 0 0 1
Fusobacterium canifelinum 0 0 0 1 0 0 1
Fusobacterium gonidiaformans 0 0 0 0 1 0 1
Fusobacterium nucleatum 0 0 0 1 0 0 1
Fusobacterium periodonticum 0 0 0 6 1 0 7
Enterobacter aerogenes 22 39 12 4 0 29 106
Enterobacter cloacae 2 0 0 0 0 0 2
Granulicatella adiacens 0 0 4 0 0 0 4
Gemella haemolysans 1 0 0 0 3 0 4
Gemella morbillorum 1 0 0 2 2 0 5
Gemella sanguinis 2 0 1 4 2 0 9
Megasphaera micronuciformis 0 0 0 3 0 0 3
Klebsiella oxytoca 4 21 4 0 0 15 44
Klebsiella pneumoniae 7 40 7 18 0 5 77
Lactobacillus fermentum 0 0 2 0 0 3 5
Lactobacillus plantarum 0 0 0 0 0 1 1
Lactobacillus salivarius 0 0 2 0 0 2 4
Leuconostoc citreum 0 0 0 0 0 3 3
Micrococcus luteus 2 0 0 2 0 0 4
Neisseria bacilliformis 2 0 0 0 0 0 2
Neisseria cinerea 2 0 0 0 0 0 2
Neisseria elongate 1 0 0 0 0 0 1
Neisseria flavescens 92 0 69 1 0 0 162
Neisseria macacae 10 0 8 0 0 0 18
Neisseria meningitidis 0 0 1 0 0 0 1
Neisseria mucosa 15 0 2 0 0 0 17
Neisseria perflava 27 0 10 0 0 0 37
Neisseria sicca 2 0 0 0 0 0 2
Neisseria subflava 15 0 21 0 0 0 36
Neisseria spp. 4 0 6 0 0 1 11
Parvimonas micra 0 0 0 1 0 0 1
Peptostreptococcus anaerobius 0 0 0 14 0 0 14
Prevotella melaninogenica 0 0 0 2 2 0 4
Prevotella pallens 0 0 0 2 0 0 2
(Continued to the next page)
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rial reads identified simultaneously by culture was 47.1% on av-
erage, ranging from 3.2% to 88.0% in the 27 samples. The bac-
teria present in BAL fluids according to the identification method 
(NGS, culture, or both) are shown in Fig. 2. Of the 156 bacterial 
BAP MAC CHO BRU PE SDA Total
Propionibacterium acnes 0 0 0 0 1 0 1
Pseudomonas aeruginosa 2 3 2 0 0 0 7
Rothia aeria 2 0 0 0 0 0 2
Rothia dentocariosa 25 0 12 0 0 0 37
Rothia mucilaginosa 75 0 41 0 1 4 121
Staphylococcus aureus 9 0 11 5 6 8 39
Staphylococcus epidermidis 3 0 2 15 0 3 23
Staphylococcus hominis 0 0 0 0 0 2 2
Staphylococcus warneri 0 0 3 1 0 0 4
Streptococcus agalactiae 0 0 0 1 0 0 1
Streptococcus anginosus 3 0 2 1 17 0 23
Streptococcus constellatus 0 0 1 6 12 0 19
Streptococcus cristatus 1 0 0 2 0 0 3
Streptococcus dentriousetti 0 0 1 0 0 0 1
Streptococcus gordonii 2 0 0 2 2 0 6
Streptococcus hominis 0 0 0 0 0 1 1
Streptococcus infantis 1 0 1 1 0 0 3
Streptococcus intermedius 0 0 0 0 2 0 2
Streptococcus mitis 10 0 6 11 14 0 41
Streptococcus oralis 7 0 4 16 6 0 33
Streptococcus parasanguinis 58 0 7 76 149 8 298
Streptococcus pasteuri 0 0 1 0 0 0 1
Streptococcus pectoris 7 0 1 10 7 0 25
Streptococcus pneumoniae 18 0 2 68 34 1 123
Streptococcus pyogenes 0 0 0 3 1 0 4
Streptococcus salivarius 59 0 146 66 158 163 592
Streptococcus sanguinis 5 0 7 2 5 0 19
Streptococcus sobrinus 0 0 1 0 0 0 1
Streptococcus vestibularis 4 0 9 1 3 0 17
Haemophilus influenzae 0 0 1 0 0 0 1
Haemophilus parahaemolyticus 0 0 3 0 0 0 3
Haemophilus parainfluenzae 1 0 33 6 0 0 40
Veillonella atypica 0 0 0 30 6 0 36
Veillonella dispar 0 0 0 18 3 0 21
Veillonella parvula 0 0 0 11 1 0 12
Veillonella salivarius 0 0 0 0 0 0 0
Veillonella spp. 0 0 0 2 1 0 3
Aspergillus fumigatus 0 0 0 0 0 5 5
Candida albicans 0 0 1 0 0 1 2
Candida glabrata 0 0 0 0 0 0 0
Total 518 104 475 449 471 255 2,272
Abbreviations: BAP, Blood agar plate; MAC, MacConkey agar plate; CHO, Chocolate agar plate; BRU, Brucella agar plate; PE, Phenylethyl alcohol agar plate; 
SDA, Sabouraud dextrose agar plate.
Table 2. Continued
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Fig. 1. Number of the operational taxonomic units and genera iden-
tified by culture and 16S rRNA next generation sequencing analysis.
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Fig. 2. Bacterial genera identified using culture with/without sequencing and 16S rRNA next generation sequencing analysis.
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Table 3. Microbial genera identified solely by culture and not by 
16S rRNA next generation sequencing analysis
Genus Number of samples (%)
Staphylococcus 8 (20.5)
Clostridium 7 (17.9)
Aspergillus 5 (12.8)
Klebsiella 4 (10.3)
Bifidobacterium 3 (7.7)
Candida 2 (5.1)
Enterobacter 2 (5.1)
Bacillus 1 (2.6)
Corynebacterium 1 (2.6)
Escherichia 1 (2.6)
Lactobacillus 1 (2.6)
Leuconostoc 1 (2.6)
Micrococcus 1 (2.6)
Pseudomonas 1 (2.6)
Slackia 1 (2.6)
genera identified solely by NGS with >1% relative abundance, 
Prevotella spp. was the most common (14.1%) and frequent 
(22 of 27 samples, 81.5%) genus. When considered as relative 
abundance, the genus Prevotella spp. comprised over 50% of 
the bacteria that were sequenced but not cultured. Interestingly, 
some bacteria were identified solely by culture; of these, Staphy-
lococcus spp., Clostridium spp., and Enterobacteriaceae includ-
ing Klebsiella spp. were common, comprising 66.7% (18/27) of 
the 27 samples and 56.4% (22/39) of the total number of colo-
nies that were cultured but not sequenced (Table 3). We per-
formed organism-specific PCR using the primers detailed in Ta-
ble 1 to detect Staphylococcus spp., Klebsiella spp., and En-
terobacter spp. All PCRs failed to amplify the target organisms 
in the samples, suggesting DNA instability in clinical samples. 
Candida and Aspergillus spp. were only cultured because they 
cannot be identified by 16S rRNA PCR.
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DISCUSSION
The purpose of this study was to evaluate the ability of the stan-
dard culture identification method used in clinical microbiology 
laboratories to elucidate microbial community profiles in BAL 
fluids. We compared the BAL fluid microbiota profiles identified 
by two methods: culture with MALDI-TOF MS and NGS. As ex-
pected, we failed to detect many strict anaerobic bacteria with 
the culture method. The most common bacteria identified solely 
by 16S rRNA NGS were Prevotella spp., which are abundant in 
respiratory specimens [18]. In a previous study, Prevotella spp. 
were the most abundant OTUs in BAL fluid followed by Strepto-
coccus spp. and Neisseria spp. [19]. Prevotella spp. were iso-
lated on Brucella or PE agar in only five samples, although se-
quencing identified this genus in all 27 samples. Interestingly, 
positive correlations between bacterial spp. and culture media 
were noted. For example, Streptococcus spp. grew prominently 
in chocolate agar under 5% CO2, and Brucella agar under an-
aerobic conditions. In addition, it is difficult to determine whether 
some of the OTUs detected solely by NGS might be contaminants 
[20].
Other bacteria that could not be cultured included many an-
aerobes such as Porphyromonas spp. and Leptotrichia spp. Fail-
ure of anaerobic culture is the most likely reason, although the 
viability of the sequenced bacteria without growth in culture me-
dia must be considered. It is interesting that despite the limita-
tions of the culture conditions adopted in this study, some bac-
terial species, including Staphylococcus spp., Clostridium spp., 
and Bifidobacterium spp. were cultured, but not sequenced. 
Selective media (MacConkey agar and PE agar) and enriched 
media (chocolate and Brucella agar) were successful in identify-
ing bacteria that were not detected using NGS. We hypothesize 
that culture can be more sensitive than sequencing in terms of 
detection under certain conditions and for some bacterial spe-
cies, as shown in previous studies for Staphylococcus aureus 
[10] and Bifidobacterium spp. [21]. We assume that the bacte-
ria identified solely by culture existed in very low quantities and 
thus failed to be sequenced. Another possible explanation is that 
the growth of some bacteria may be affected by culture media 
in association with other co-existing bacteria. The use of mixed 
culture via co-cultivation with helper strains could be used to fa-
cilitate growth [22, 23]. As previously reported, the information 
provided by metagenomic approaches can be limited [24]. Many 
pre-analytical, analytical, and post-analytical factors can affect 
the outcome. DNA extraction is another step that can influence 
sequencing results [25-27]. DNA isolation methods, the 16S 
rRNA target region used for PCR, and sequencing vary widely, 
and differences in techniques and manufacturers’ kits may pro-
duce disparate data [28]. In this study, the V1-V3 region (27F-
518R) of the 16S rRNA gene was amplified, because it is one of 
the most reliable targets for taxonomy. However, a sequencing 
depth of 10,332 valid reads per sample on average could affect 
the identification results. In addition, the culture method enabled 
the identification of fungi, such as Candida and Aspergillus, which 
cannot be detected by 16S rRNA sequencing.
It is known that a large proportion of the microbes found in 
the human gastrointestinal tract are unculturable [29, 30], al-
though this has been challenged by recent studies revealing 
many rare microorganisms. Metagenomics by deep sequencing 
is undoubtedly a powerful tool in microbial community analysis; 
however, it possesses some limitations. Sequenced DNA is not 
evidence of viable bacteria, and detection sensitivity is depen-
dent on sequencing depth, which may result in a failure to iden-
tify low-abundance bacterial species. NGS approaches, espe-
cially those based on amplification of the highly conserved 16S 
rRNA gene, are inherently incapable of detecting intra-species 
variations [24]. Cultivation of microbes provides a greater un-
derstanding of bacterial interactions and traits and can be used 
to obtain completely sequenced genomes from these species. 
In addition, currently, the culture method with MALDI-TOF MS 
has advantages over NGS, in terms of cost and practical appli-
cation. Although NGS has reduced the cost of sequencing greatly, 
it is still a fairly expensive technology and requires bioinformatic 
tools for analysis. 
Recent efforts in developing culture methods have enabled 
the culture of previously ‘as-yet uncultured’ bacteria, known as 
culturomics [10, 31, 32]. The use of several different culture 
conditions has enabled the isolation of new bacterial species, 
the largest human virus, the largest bacterium, and the largest 
archaeon from humans [33]. One study demonstrated that anal-
yses of the same samples produced only partially overlapping 
results; 51 of the 340 species and 698 phylotypes were identi-
fied by culturomics and metagenomic analysis, respectively [10]. 
However, various culture conditions, including many nonselec-
tive and selective culture media used in culturomics, are not prac-
tical for application in conventional clinical microbiology labora-
tories. MALDI-TOF MS is another powerful tool used in micro-
bial identification. MALDI-TOF MS has allowed for the accurate 
identification of a large panel of anaerobes that are poorly iden-
tified because of ambiguous or erroneous results using conven-
tional methods. Coupling MALDI-TOF MS with culturomics has 
enabled the identification of a large collection of bacterial spe-
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cies, including anaerobes that are usually poorly identified with 
current phenotypic methods, from stool specimens [34]. When 
a limited number of culture conditions commonly used in clini-
cal microbiology laboratories were applied, all the isolated bac-
teria were present in the MALDI-TOF MS database, although 
some bacteria were poorly identified and needed further 16S 
rRNA or ITS sequencing. 
Our study has some limitations. We used limited types of cul-
ture media commonly used in clinical microbiology laboratories. 
While picking the colonies from each agar plate, some bacteria 
may have been missed because of selection bias. The agar plates 
were incubated for only 48 hours; this duration may not have 
been adequate for slow-growing microorganisms. Although we 
tried to inoculate the samples as soon as possible and within 6 
hours post collection, some anaerobic bacteria may have been 
lost during the prolonged oxygen exposure. The number of reads, 
~10,000 per sample on an average in this study, may also affect 
the bacterial species detected in each sample. Most of the bac-
terial species were successfully identified using MALDI-TOF MS. 
However, the reliability of streptococci identification might not be 
high because of the inherent limitations of MALDI-TOF MS. Lastly, 
we did not quantify the microorganisms in in culture method, which 
is a limitation in exploring microbial diversity. 
To the best of our knowledge, this is the first study to evaluate 
the use of conventional culture methods combined with MALDI-
TOF MS in microbiome analysis of BAL fluid samples compared 
with 16S rRNA NGS. Some bacteria, mainly anaerobes, failed to 
grow on conventional culture media, and less diverse microbial 
communities were identified with the culture method. However, 
interestingly, some common bacteria were not identified by se-
quencing, but were cultured, indicating the significance of cul-
ture in microbiome analysis. Despite a number of limitations, 
culture methods with MALDI-TOF MS may play a significant role 
in microbiome analysis that is complementary to 16S rRNA NGS. 
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